A Randomized Non Comparative Phase II Study of Lacutamab With GemOx Versus GemOx Alone in Relapsed/Refractory Patients With Peripheral T-cell Lymphoma
Latest Information Update: 05 Sep 2024
At a glance
- Drugs Lacutamab (Primary) ; Gemcitabine; Oxaliplatin
- Indications Adult T-cell leukaemia-lymphoma; Anaplastic large cell lymphoma; Follicular lymphoma; Large granular lymphocytic leukaemia; Peripheral T-cell lymphoma; T-cell lymphoma
- Focus Therapeutic Use
- Acronyms KILT
- 12 Jun 2023 According to an Innate Pharma media release, trial in progress from this study has been published in the 17th International Conference on Malignant Lymphoma abstract book available online.
- 10 Jun 2022 Results published in the Blood
- 06 Dec 2021 Status changed from not yet recruiting to recruiting.